• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在对卵巢癌、输卵管癌或原发性腹膜癌进行剖腹手术时,使用透明质酸钠-羧甲基纤维素(HA-CMC)屏障预防术后腹腔内积液。

Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers.

作者信息

Leitao Mario M, Natenzon Anna, Abu-Rustum Nadeem R, Chi Dennis S, Sonoda Yukio, Levine Douglas A, Gardner Ginger J, Barakat Richard R

机构信息

Division of Gynecology, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

出版信息

Gynecol Oncol. 2009 Nov;115(2):204-8. doi: 10.1016/j.ygyno.2009.08.005. Epub 2009 Sep 8.

DOI:10.1016/j.ygyno.2009.08.005
PMID:19740532
Abstract

OBJECTIVES

To determine whether HA-CMC was associated with the development of postoperative intra-abdominal collections in patients undergoing laparotomy for ovarian, fallopian tube, or primary peritoneal malignancies.

METHODS

We retrospectively identified all laparotomies performed for these malignancies from March 1, 2005 to December 31, 2007. The use of HA-CMC was identified. Laparotomies for malignant bowel obstruction or repair of fistulae were excluded. Intra-abdominal collections, non-infected and infected, were defined as localized intraperitoneal fluid accumulations in the absence of re-accumulating ascites. All other complications were also captured. Appropriate statistical tests were applied using SPSS 15.0.

RESULTS

We identified 219 laparotomies with HA-CMC and 204 without HA-CMC. Upper abdominal resections were performed in 65/219 (30%) HA-CMC cases compared to 39/204 (19%) cases without HA-CMC (P=0.01). The rates of large bowel and/or rectal resections were similar in both cohorts. Intra-abdominal collections were seen in 18/219 (8.2%) HA-CMC cases compared to 5/204 (2.5%) cases without HA-CMC (P=0.009). HA-CMC was independently associated with the diagnosis of a postoperative intra-abdominal collection (P=0.01). All but 2 collections developed in patients undergoing debulking procedures.

CONCLUSIONS

HA-CMC appears to be associated with a higher rate of postoperative intra-abdominal collections. This seems to be greatest in patients who are undergoing a debulking procedure.

摘要

目的

确定透明质酸-羧甲基纤维素(HA-CMC)与接受卵巢、输卵管或原发性腹膜恶性肿瘤剖腹手术患者术后腹腔内积液的发生是否相关。

方法

我们回顾性确定了2005年3月1日至2007年12月31日期间因这些恶性肿瘤进行的所有剖腹手术。确定了HA-CMC的使用情况。排除恶性肠梗阻或瘘管修复的剖腹手术。腹腔内积液,包括非感染性和感染性,定义为在无再积聚腹水情况下的局限性腹腔内液体聚集。还记录了所有其他并发症。使用SPSS 15.0进行适当的统计检验。

结果

我们确定了219例使用HA-CMC的剖腹手术和204例未使用HA-CMC的剖腹手术。在使用HA-CMC的219例病例中有65例(30%)进行了上腹部切除术,而未使用HA-CMC的204例病例中有39例(19%)进行了上腹部切除术(P=0.01)。两个队列中大肠和/或直肠切除术的发生率相似。使用HA-CMC的219例病例中有18例(8.2%)出现腹腔内积液,而未使用HA-CMC的204例病例中有5例(2.5%)出现腹腔内积液(P=0.009)。HA-CMC与术后腹腔内积液的诊断独立相关(P=0.01)。除2例积液外,所有积液均发生在进行减瘤手术的患者中。

结论

HA-CMC似乎与术后腹腔内积液的发生率较高相关。这在进行减瘤手术的患者中似乎最为明显。

相似文献

1
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers.在对卵巢癌、输卵管癌或原发性腹膜癌进行剖腹手术时,使用透明质酸钠-羧甲基纤维素(HA-CMC)屏障预防术后腹腔内积液。
Gynecol Oncol. 2009 Nov;115(2):204-8. doi: 10.1016/j.ygyno.2009.08.005. Epub 2009 Sep 8.
2
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers.在子宫颈癌或子宫癌开腹手术时使用透明质酸钠-羧甲基纤维素(HA-CMC)屏障进行术后腹腔内积血。
Gynecol Oncol. 2010 Nov;119(2):208-11. doi: 10.1016/j.ygyno.2010.07.027. Epub 2010 Aug 12.
3
Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers.分析细胞减灭术后使用透明质酸钠-羧甲基纤维素(HA-CMC)防粘连屏障与卵巢、输卵管和腹膜癌相关的术后并发症。
Gynecol Oncol. 2011 Feb;120(2):220-3. doi: 10.1016/j.ygyno.2010.10.037. Epub 2010 Dec 8.
4
Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier.使用透明质酸钠-羧甲基纤维素(HA-CMC)屏障预防根治性卵巢切除术后粘连形成。
Gynecol Oncol. 2005 Nov;99(2):301-8. doi: 10.1016/j.ygyno.2005.06.057. Epub 2005 Aug 8.
5
The efficacy of a hyaluronate-carboxymethylcellulose bioresorbable membrane that reduces postoperative adhesions is increased by the intra-operative co-administration of a neurokinin 1 receptor antagonist in a rat model.在大鼠模型中,术中联合给予神经激肽 1 受体拮抗剂可提高减少术后粘连的透明质酸-羧甲基纤维素生物可吸收膜的疗效。
Surgery. 2010 Nov;148(5):991-9. doi: 10.1016/j.surg.2010.01.024. Epub 2010 Mar 24.
6
The use of sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier in gynecologic malignancies: a retrospective review of outcomes.透明质酸钠-羧甲基纤维素(HA-CMC)屏障在妇科恶性肿瘤中的应用:结局的回顾性分析
Ann Surg Oncol. 2009 Feb;16(2):499-505. doi: 10.1245/s10434-008-0235-1. Epub 2008 Nov 19.
7
Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers.原发性卵巢癌、输卵管癌和原发性腹膜癌初次手术后的腹疝。
Gynecol Oncol. 2011 Jan;120(1):33-7. doi: 10.1016/j.ygyno.2010.09.015. Epub 2010 Oct 13.
8
Does hyaluronic acid-carboxymethylcellulose (HA-CMC) membrane interfere with the healing of intestinal suture lines and abdominal incisions?透明质酸-羧甲基纤维素(HA-CMC)膜会干扰肠道缝合线和腹部切口的愈合吗?
Surg Innov. 2005 Mar;12(1):37-41. doi: 10.1177/155335060501200106.
9
A membrane slurry reduces postoperative adhesions in rat models of abdominal surgery.膜浆液可减少腹部手术大鼠模型中的术后粘连。
J Surg Res. 2011 Jun 1;168(1):e25-30. doi: 10.1016/j.jss.2010.02.009. Epub 2010 Mar 5.
10
A multicentre, randomised, controlled trial to assess the safety, ease of use, and reliability of hyaluronic acid/carboxymethylcellulose powder adhesion barrier versus no barrier in colorectal laparoscopic surgery.一项多中心、随机、对照试验,旨在评估透明质酸/羧甲基纤维素粉末粘连屏障与无屏障在结直肠腹腔镜手术中的安全性、易用性和可靠性。
Trials. 2014 Oct 27;15:413. doi: 10.1186/1745-6215-15-413.

引用本文的文献

1
Seprafilm and adhesive small bowel obstruction in colorectal/abdominal surgery: an updated systematic review.Seprafilm 在结直肠/腹部手术中与黏连性小肠梗阻:一项更新的系统评价。
BMC Surg. 2024 Oct 5;24(1):291. doi: 10.1186/s12893-024-02581-2.
2
Techniques for navigating postsurgical adhesions: Insights into mechanisms and future directions.术后粘连的导航技术:对机制及未来方向的见解
Bioeng Transl Med. 2023 Jun 26;8(6):e10565. doi: 10.1002/btm2.10565. eCollection 2023 Nov.
3
Absorptive anti-adhesion barrier for the prevention of bowel obstruction after laparoscopic colorectal cancer surgery.
用于预防腹腔镜结直肠癌手术后肠梗阻的吸收性抗粘连屏障。
J Anus Rectum Colon. 2018 Mar 9;2(1):1-8. doi: 10.23922/jarc.2017-026. eCollection 2018.
4
Utilization and safety of sodium hyaluronate-carboxymethylcellulose adhesion barrier.透明质酸钠羧甲基纤维素防粘连膜的使用和安全性。
Dis Colon Rectum. 2013 Oct;56(10):1174-84. doi: 10.1097/DCR.0b013e31829ec889.
5
Seprafilm(®) adhesion barrier: (2) a review of the clinical literature on intraabdominal use.施沛特(®)粘连屏障:(2)关于腹腔内使用的临床文献综述
Gynecol Surg. 2012 Sep;9(3):247-257. doi: 10.1007/s10397-012-0742-8. Epub 2012 Apr 15.